In the current study, better glycemic control, was associated with reduced risk of retinopathy, supporting data from other studies [5,7] Insulin treatment was associated with NPDR development, regardless of the HbA1c level. The gene discussed is INS; the disease is non-proliferative diabetic retinopathy.